PROTOCOL SUMMARY FOR PATIENTS

View Professional Summary

Safety, Tolerability and PK of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib

Safety, Tolerability and PK of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib


Basic Trial Information

Protocol Phase:Phase I
Study Category:Treatment
Current Protocol StatusActive
Age18 and over
Protocol SponsorPharmaceutical/Industry
Primary IDC14015
Other IDNCT01844583
Special Category

TRIAL DESCRIPTION

Purpose:
Eligibility:
Treatment Intervention:
Patient Disclaimer: